NICE appraisals should be everybody's business

AUTOR(ES)

Wells, Jane

FONTE

BMJ Publishing Group Ltd.

RESUMO

When Newbury and Community Primary Care Trust appealed against NICE's decision on Herceptin, it was the first to do so. Jane Wells and Claire Cheong-Leen explain the process and why other trusts should make their voices heard in appraisals of new treatments

Documentos Relacionados

• Role of NICE should be expanded, MPs told
• NICE and its value judgments: Option of safe “understudy” treatments should be available
• Everybody's talking: using entertainment–education video to reduce barriers to discussion of cervical cancer screening among Thai women
• Economist says NICE should approve fewer costly drugs
• NICE says that patients' age should affect treatment